Page last updated: 2024-11-11

a 70450

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

A 70450: inhibitor of aspartyl proteinase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID22844441
SCHEMBL ID7343870
MeSH IDM0221181

Synonyms (8)

Synonym
a 70450
142928-23-2
2-(3-benzyl-4-n-(4-methylpiperazin-1-yl-carbonyl)-2-ketopiperazin-1-yl)hexanoic acid amide
cyclohexanehexanamide, delta-amino-n-butyl-gamma-hydroxy-alpha-(1-methylethyl)-, monohydrochloride, (alphar-(alphar*,gammas*,deltas*))-
SCHEMBL7343870
5-amino-n-butyl-6-cyclohexyl-4-hydroxy-2-(propan-2-yl)hexanimidic acid--hydrogen chloride (1/1)
DTXSID60931684
(2r,4s,5s)-5-amino-n-butyl-6-cyclohexyl-4-hydroxy-2-propan-2-ylhexanamide;hydrochloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]